Recent advances in imidazoline receptor research: Ligands-localization and isolation-signaling-functional and clinical studies

Journal of the Autonomic Nervous System

Volumn 72, Issue 2-3, 1998, Pages 74-79

  Head, Geoffrey A ^a   Gundlach, Andrew L ^b   Musgrave, Ian F ^c  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Blood pressure; Brain, kidney and adrenal gland; Cloning; Endogenous ligands; Human and rodent; Imidazoline receptors; Monoamine oxidase; Signal transduction

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING); CLONIDINE; IMIDAZOLINE RECEPTOR; RILMENIDINE;

AUTONOMIC NERVOUS SYSTEM; BINDING SITE; BLOOD PRESSURE; BRAIN; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; KIDNEY; LIGAND BINDING; MEDICAL RESEARCH; MOLECULAR CLONING; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; IMIDAZOLES; LIGANDS; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0031752445     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(98)00090-3     Document Type: Conference Paper

References (51)

1. Atlas, D., Burnstein, Y., 1984. Isolation and partial purification of a clonidine displacing substance. Eur. J. Biochem. 144, 287-293.
2. Auguet, M., Viossat, I., Marin, J.G., Chabrier, P.E., 1995. Selective inhibition of inducible nitric oxide synthase by agmatine. Jpn. J. Pharmacol. 69, 285-287.
3. Bousquet, P., Feldman, J., Schwartz, J., 1984. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230, 232-236.
4. Burke, S.L., Malpas, S.C., Head, G.A., 1998. Effect of rilmenidine on cardiovascular responses to stress in the conscious rabbit. J. Auton. Nerv. Syst. 72, 177-186.
5. Campbell, W.R., Potter, D.E., 1995. Centrally mediated ocular hypotension: potential role of imidazoline receptors. Anal. N.Y. Acad. Sci. 763, 463-485.
6. 1-imidazoline receptors. J. Auton. Nerv. Syst. 72, 147-154.
7. 1-imidazoline binding sites. Neurochem. Int. 30, 17-23.
8. Ernsberger, P., Guiliano, R., Willette, R.N., Reis, D.J., 1990. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253, 408-418.
9. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20, S1-S10, suppl. 4.
10. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264, 172-182.
11. Escriba, P.V., Ozaita, A., Miralles, A., Reis, D.J., Garcia-Sevilla, J.A., 1995. Molecular characterization and isolation of a 45-kilodalton imidazoline receptor protein from the rat brain. Mol. Brain Res. 32, 187-196.
12. Esler, M., Kaye, D., 1998. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J. Auton. Nerv. Syst. 72, 210-219.
13. 1) receptors and renal mechanisms in relation to their antihypertensive therapeutic potential. Clin. Exp. Pharmacol. Physiol. 23, 845-854.
14. Feldman, J., Bousquet, P., 1998. Does a second generation of centrally acting antihypertensive drugs really exist?. J. Auton. Nerv. Syst. 72, 94-97.
15. Godwin, S.J., Tortelli, C.F., Parkin, M.L., Head, G.A., 1998. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine. J. Auton. Nerv. Syst. 72, 195-204.
16. Gomez, R.E., Ernsberger, P., Feinland, G., Reis, D.J., 1991. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol. 195, 181-191.
17. Grigg, M., Musgrave, I.F., Barrow, C.J., 1998. Isolation and partial structure determination of a clonidine-displacing substance (CDS) from bovine lung and brain. J. Auton. Nerv. Syst. 72, 86-93.
18. Guyenet, P.G., 1997. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am. J. Physiol. 42, R1580-R1584.
19. 2-Adrenergic receptors rather than 'imidazoline' binding sites mediate the sympatholytic effect of clonidine in the rostral ventrolateral medulla: a new look at the evidence. In: Trouth, O., Millis, R., Kiwull-Schone, H., Schlafke, M.E. (Eds.), Ventral Brainstem Mechanisms and Control Functions, Marcel Dekker, New York, pp. 281-303.
20. 1-Imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24, S1-S8, suppl. 1.
21. Head, G.A., 1995. Baroreflexes and cardiovascular regulation in hypertension. J. Cardiovasc. Pharmacol. 26, S7-S16, suppl. 2.
22. Head, G.A., Burke, S.L., Chan, C.K.S., 1997. Central imidazoline receptors and centrally acting anti-hypertensive agents. Clin. Exp. Hypertens. 19, 591-605.
23. 2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J. Auton. Nerv. Syst. 72, 163-169.
24. Hieble, J.P., Ruffolo, R.R., 1992. Imidazoline receptors - historical perspective. Fundam. Clin. Pharmacol. 6, S7-S13.
25. 3H]rilmenidine binding sites in rat brain. J. Auton. Nerv. Syst. 72, 129-136.
26. Ivanov, T.R., Jones, J.C., Dontenwill, M., Bousquet, P., Piletz, J.E., 1998. Characterization of a partial cDNA clone detected by imidazoline receptor-selective antisera. J. Auton. Nerv. Syst., this issue.
27. 3H]rilmenidine. Brain Res. 675, 264-278.
28. 3H]imidazoline binding sites in rat kidney. Eur. J. Pharmacol. 281, 341-346.
29. 3H]2-BFI-labelled I-RBS and MAO-B in rabbit, but not rat, kidney. J. Auton. Nerv. Syst. 72, 118-128.
30. Li, G., Regunathan, S., Barrow, C.J., Eshraghi, J., Cooper, R., Reis, D.J., 1994. Agmatine - an endogenous clonidine-displacing substance in the brain. Science 263, 966-969.
31. 2A-adrenergic receptor subtype. Science 273, 801-803.
32. McConnell, H.M., Owicki, J.C., Parce, J.W., Miller, D.L., Baxter, G.T., Wada, H.G.S.P., 1992. The cytosensor microphysiometer: biological applications of silicon technology. Science 257, 1906-1912.
33. Medvedev, O.S., Kunduzova, O.R., Murashev, A.N., Medvedeva, N.A., 1998. Influence of sino-aortic barodenervation on the cardiovascular effects of imidazoline-like drugs. J. Auton. Nerv. Syst. 72, 205-209.
34. Meeley, M.P., Ernsberger, P.R., Granata, A.R., Reis, D.J., 1986. An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. Life Sci. 38, 1119-1126.
35. Michel, M.C., Ernsberger, P., 1992. Keeping an eye on the I site: imidazoline-preferring receptors. Trends Pharmacol. Sci. 13, 369-370.
36. Munk, S.A., Lai, R.K., Burke, J.E., Arasasingham, P.N., Kharlamb, A.B., Manlapaz, C.A., Padillo, E.U., Wijono, M.K., Hasson, D.W., Wheeler, L.A., Garst, M.E., 1996. Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazoline1 receptor specific agent. J. Med. Chem. 39, 1193-1195.
37. 1-imidazoline receptors using microphysiometry and molecular modelling. J. Auton. Nerv. Syst. 72, 137-146.
38. Musgrave, I.F., Krautwurst, D., Hescheler, J., Schultz, G., 1995. Clonidine and cirazoline inhibit activation of nicotinic channels in PC-12 cells. Anal. N.Y. Acad. Sci. 763, 272-282.
39. Musgrave, I.E., Krautwurst, D., Schultz, G., 1996. Imidazoline binding sites and signal transduction pathways. Clin. Exp. Pharmacol. Physiol. 23, 990-994.
40. 2-adrenergic receptors: implications for depression. CRC Rev. Neurobiol. 9, 29-66.
41. Pineda, J., Ruiz-Ortega, J.A., Martin-Ruiz, R., Ugedo, L., 1996. Agmatine does not have activity at alpha 2-adrenoceptors which modulate the firing rate of locus coeruleus neurones: an electrophysiological study in rat. Neurosci. Lett. 219, 103-106.
42. Pinthong, D., Wright, I.K., Hanmer, C., Millns, P., Mason, R., Kendall, D.A., Wilson, V.G., 1995. Agmatine recognizes alpha 2-adrenoceptor binding sites but neither activates nor inhibits alpha 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 10-16.
43. Punnen, S., Urbanski, R., Krieger, A.J., Sapru, H.N., 1987. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 422, 336-346.
44. Raddatz, R., Parini, A., Lanier, S.M., 1997. Localization of the imidazoline binding domain on monoamine oxidase B. Mol. Pharmacol 52, 549-553.
45. Regunathan, S., Reis, D.J., 1996. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36, 511-544.
46. Reis, D.J., Regunathan, S., 1998. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain. J. Auton. Nerv. Syst. 72, 80-85.
47. Reis, D.J., Regunathan, S., Golanov, E.V., Feinstein, D.L., 1994. Protection of focal ischemic infarction by rilmenidine in the animal: evidence that interactions with central imidazoline receptors may be neuroprotective. Am. J. Cardiol. 74, A25-A30.
48. 3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver. J. Auton. Nerv. Syst. 72, 111-117.
49. 1-Imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. 49, 668-675.
50. Smyth, D.D., Penner, S.B., 1998. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?. J. Auton. Nerv. Syst. 72, 155-162.
51. Timmermans, P.B.M.W.M., Van Zwieten, P.A., 1981. Characterisation of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine. Eur. J. Pharmacol. 70, 7-15.